A Study to Evaluate Safety, Tolerability and P-Glucose After Multiple Ascending Oral Doses of AZD1656 in Type 2 Diabetes

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

April 30, 2009

Study Completion Date

April 30, 2009

Conditions

Type 2 Diabetes

Interventions

DRUG

AZD1656

Dose titration to 3 (alt 4) increasing dose-steps with oral suspension, 8 days treatment

DRUG

AZD1656

Dose titration of oral suspension to a tolerable dose, 1 month treatment

Trial Locations (1)

Research Site, Chula Vista